Astra Zeneca: brand value worldwide 2021-2024

Published by Statista Research Department, Nov 20, 2024

In 2024, the brand value of Astra Zeneca - a pharmaceutical brand currently most often associated with the Oxford–AstraZeneca COVID-19 vaccine - stood at 5.73 billion U.S. dollars. In 2022, the revenue of the global pharmaceutical industry was almost 1.5 trillion U.S. dollars.

Brand value of Astra Zeneca worldwide from 2021 to 2024 (in billion U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

July 2024

Region

Worldwide, United Kingdom

Survey time period

2021 to 2024

Supplementary notes

Figures preceding 2023 retrieved from earlier reports.

Figures have been rounded.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Brand value "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Brand value

Global overview

5

Regional overview

6

Leading countries

8

Industry leaders

8

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Sputnik V COVID-19 vaccineAstraZenecaCoronavirus disease (COVID-19) pandemicCoronavirus (COVID-19) vaccines and treatmentsCoronavirus (COVID-19) in Russia
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.